Novel Strategies to Target Inflammatory Processes in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|9|1616-1625

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-01, pp. : 1616-1625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1216-1227

Bentham Science Publishers

Access to resources Recommend Favorite

Development of novel therapeutic strategies that target HIF-1

By Semenza Gregg L  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 267-280

Informa Healthcare

Access to resources Recommend Favorite

The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity

By Ulrich-Merzenich Gudrun  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 905-919

Informa Healthcare

Access to resources Recommend Favorite

MK2: a novel molecular target for anti-inflammatory therapy

By Duraisamy Senthil   Bajpai Malini   Bughani Usha   Dastidar Sunanda G   Ray Abhijit   Chopra Puneet  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 921-936

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite